Canopy Growth Stock Forecast, Price & News

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 2 sell ratings, 10 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Canopy Growth stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CGC, but not buy additional shares or sell existing shares.
View analyst ratings for Canopy Growth or view top-rated stocks.

Wall Street analysts have given Canopy Growth a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Canopy Growth wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Canopy Growth is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Canopy Growth.

Canopy Growth Co. (NASDAQ:CGC) issued its quarterly earnings data on Monday, May, 31st. The company reported ($1.85) earnings per share for the quarter, missing analysts' consensus estimates of ($0.18) by $1.67. The business earned $167.40 million during the quarter, compared to analysts' expectations of $149.97 million. Canopy Growth had a negative trailing twelve-month return on equity of 18.67% and a negative net margin of 311.30%. The firm's revenue for the quarter was up 45.4% compared to the same quarter last year. During the same period in the prior year, the company posted ($3.72) EPS.
View Canopy Growth's earnings history.

Canopy Growth's stock was trading at $13.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CGC stock has increased by 93.8% and is now trading at $25.87.
View which stocks have been most impacted by COVID-19.

16 Wall Street analysts have issued 1-year price objectives for Canopy Growth's stock. Their forecasts range from $21.10 to $55.00. On average, they expect Canopy Growth's share price to reach $32.90 in the next twelve months. This suggests a possible upside of 27.2% from the stock's current price.
View analysts' price targets for Canopy Growth or view top-rated stocks among Wall Street analysts.

Some companies that are related to Canopy Growth include (ALIOF) (ALIOF), Tilray (TLRY), STADA Arzneimittel Aktiengesellschaft (STDAF), Cronos Group (CRON), USANA Health Sciences (USNA), Aurora Cannabis (ACB), Sundial Growers (SNDL), HEXO (HEXO), ChromaDex (CDXC), Canopy Rivers (RIV), MediWound (MDWD), Charlie's (CHUC), Natural Alternatives International (NAII), Mannatech (MTEX) and FitLife Brands (FTLF).
View all of CGC's competitors.

Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."

Canopy Growth's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Morgan Stanley (0.52%), Bank of Nova Scotia (0.47%), D. E. Shaw & Co. Inc. (0.35%), CIBC World Markets Inc. (0.35%), The Manufacturers Life Insurance Company (0.28%) and AdvisorShares Investments LLC (0.25%). Company insiders that own Canopy Growth stock include Phillip Stephen Shaer, Rade Nikola Kovacevic and Tomas Iv Shipley.
View institutional ownership trends for Canopy Growth.

CGC stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Toronto Dominion Bank, CIBC Asset Management Inc, State of Wisconsin Investment Board, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Voloridge Investment Management LLC, Dimensional Fund Advisors LP, and D. E. Shaw & Co. Inc.. Company insiders that have sold Canopy Growth company stock in the last year include Phillip Stephen Shaer, Rade Nikola Kovacevic, and Tomas Iv Shipley.
View insider buying and selling activity for Canopy Growth or view top insider-selling stocks.

CGC stock was acquired by a variety of institutional investors in the last quarter, including CIBC World Markets Inc., AdvisorShares Investments LLC, Morgan Stanley, Penserra Capital Management LLC, Mirae Asset Global Investments Co. Ltd., JPMorgan Chase & Co., Roosevelt Investment Group LLC, and Alberta Investment Management Corp.
View insider buying and selling activity for Canopy Growth or or view top insider-buying stocks.

Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CGC stock can currently be purchased for approximately $25.87.

Canopy Growth has a market capitalization of $9.91 billion and generates $414.03 million in revenue each year. The company earns $-1,322,470,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis.

Canopy Growth employs 4,434 workers across the globe.

The official website for Canopy Growth is www.canopygrowth.com.

Canopy Growth is headquartered at 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8.

Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The company can be reached via phone at 855 558 9333 or via email at [email protected]